Plante Moran Financial Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Plante Moran Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $3,630 - $4,510	-50 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $3,593 - $6,551	50 New	50 $4,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1,671 - $2,245	-26 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $241 - $281	3 Added 13.04%	26 $2,000
Q1 2019 May 13, 2019	SELL	$84.2 - $98.62 $1,263 - $1,479	-15 Reduced 39.47%	23 $2,000
Q4 2018 Jan 29, 2019	BUY	$80.14 - $106.07 $1,682 - $2,227	21 Added 123.53%	38 $3,000
Q3 2018 Nov 09, 2018	SELL	$93.92 - $105.72 $751 - $845	-8 Reduced 32.0%	17 $2,000
Q2 2018 Jul 26, 2018	SELL	$76.01 - $99.03 $3,268 - $4,258	-43 Reduced 63.24%	25 $2,000
Q4 2017 Feb 01, 2018	SELL	$80.76 - $95.13 $3,391 - $3,995	-42 Reduced 38.18%	68 $6,000
Q3 2017 Nov 08, 2017	BUY	$80.6 - $94.95 $8,866 - $10,444	110	110 $10,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.